P. Cazorla et al., LOCATION OF AN EPITOPE SHARED BY ALZHEIMERS AMYLOID PEPTIDE AND BRAINCREATINE-KINASE USING A NEWLY DEVELOPED MONOCLONAL-ANTIBODY, Biochimica et biophysica acta. Molecular basis of disease, 1270(2-3), 1995, pp. 149-156
Amyloid plaques, composed mainly by a peptide termed A4-amyloid, deriv
ed by proteolytic processing from the amyloid precursor protein (APP),
are a hallmark in the brain of Alzheimer's disease patients. We have
prepared a collection of monoclonal antibodies as tools to study APP e
xpression and proteolysis in different systems. One of these, 5AH10, r
aised against residues 9-22 of A4-peptide, was selected for its abilit
y to recognize only A4 subpeptides having the intact APP-secretase tar
get sequence, as well as whole recombinant APP. By using synthetic sub
peptides, we have located 5AH10 epitope between amino acids 15 and 22
of A4. In addition, 5AH10 showed a strong immunoreactivity to a 47 kDa
protein present in rat brain extracts, that was identified as the B (
brain specific) subunit of creatine kinase by immunochemical data and
direct N-terminal sequencing. The cross-reaction observed is most prob
ably due to a high degree of sequence identity between amino acids 15
to 22 of A4 peptide and amino acids 9 to 16 of rat B creatine kinase.
5AH10 did not recognize the muscle specific isoform (M subunit) of rat
creatine kinase, nor the B subunit of human and rabbit creatine kinas
e, suggesting that glutamine at first position of the epitope is essen
tial for antigen recognition by 5AH10.